NR1D2 and atherosclerosis: Nr1d2 also represses the expression of hepatic Apoc3 mRNA, a risk factor for atherosclerosis [38], and hepatic Insig1 overexpression reduces lipogenesis via decreased expression of Srebp1c mRNA and its target enzymes [39].